You are here

Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis

Last updated on February 28, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Jesi, Ancona, 60035 Italy
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Rheumatoid Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Inclusion Criteria Based On Clinical Practice of Aggressive RA

- Diagnosis of early aggressive RA in accordance with local guideline

- Disease duration

- Patients naïve to anti-TNFa drugs and DMARDs, including MTX, or assuming one or more
DMARD without complete response

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Exclusion Criteria Based on Clinical Practice of Aggressive RA

- Patients should not be included in the study if they have participated in any
interventional clinical trial within the previous 2 years.

NCT00267852
Pfizer
Completed
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Rheumatoid Arthritis
NCT03981900
All Genders
18+
Years
Multiple Sites
Systemic Lupus Erythematosus, Rheumatoid Arthritis
NCT03334851
All Genders
18+
Years
Multiple Sites
Crohn Desease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
NCT02925338
All Genders
6+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now